"Our other most interesting finding is that many of the active ingredients from the Cassia auriculata plant work through a process called 'synergism' - in other words, they work together to produce an effect greater than the sum of their individual effects," Dr Habtemariam says. "Overall, this suggests that the crude plant extract has lots of potential to be used clinically for treating diabetes and associated diseases."
Tuesday, January 22, 2013
Researchers identify potential sources of medicines derived from plants against diabetes
Sunday, February 1, 2009
Nano-insulin pill ?
In my earlier blog, I wrote about the use of nanoparticles in the field of Pharmaceutical will happen in the near future. But I didn’t expect it to happen so fast. Thanks to Dr.Chandra Sharma (of Sree Chitra Tirunal Institute for Medical Science & Technology,
The animal experiments demonstrated that the nanoparticles enter the bloodstream and end up in organs such as the liver and kidney and in diabetic pigs showed the pill containing the nanoparticles led to control of blood glucose after eating. Though the results are encouraging in the animal models, have to be established in human beings and also most importantly the impact of nanoparticles in human beings has to be studied thoroughly, so that a concrete and conclusive evidence will happen in the coming days. I hope this will research will open flood gate for other drugs with nanoparticles coating. More....
Tuesday, December 4, 2012
Wednesday, February 11, 2015
Diabetes drug can boost efficacy of TB medication without causing drug resistance
Monday, April 3, 2017
Liraglutide drug lowers blood sugar levels in diabetic patients taking large doses of insulin
Tuesday, June 23, 2015
Anti-diabetic medication activates brain sensors, promotes weight gain
Tuesday, April 24, 2012
Liquorice root found to contain anti-diabetic substance
Liquorice root found to contain anti-diabetic substance
Wednesday, August 5, 2015
FDA Approves Glyxambi (empagliflozin and linagliptin) for Type 2 Diabetes
Tuesday, December 20, 2016
Metformin along with chemotherapy/radiation improves outcomes in head and neck cancer patients
"In basic science studies, metformin has been shown to stop mTOR, a molecular pathway present and active in this type of head and neck cancer, and pretreatment with metformin resulted in a decrease in the occurrence of oral cavity tumors in animal models. In this study, we wanted to see if the combination of escalating doses of metformin with the chemotherapy agent cisplatin and radiation for head and neck cancer tumors in non-diabetic patients would be effective."
"This is part of an ongoing clinical trial," says Wise-Draper. "We found that eight patients with advanced head and neck cancer have been enrolled so far; we plan to have 30 total. Due to the relatively quick escalation of metformin, the patients' tolerance was poor with higher doses of metformin when initiated 7 days prior to their chemotherapy and radiation therapy regimen.
"Therefore, the protocol was modified to allow slower escalation over 14 days. The most common toxicities observed included nausea (71 percent of patients) and vomiting (43 percent of patients), increase in creatinine (57 percent of patients), decreased white blood cell count (43 percent of patients) and pain when swallowing (43 percent of patients) with only nausea being directly attributed to metformin and the rest attributed to cisplatin and radiation."
Thursday, September 8, 2011
Monday, November 16, 2009
Statins as anticancer and anti diabetic agents ?
Statins lower cholesterol by blocking certain enzymes involved in our metabolism. However, they have also been shown to affect other important lipids in the body, such as the lipids that help proteins to attach to the cell membrane (known as lipid modification). Because many of the proteins that are lipid-modified cause cancer, there are now hopes that it will be possible to use statins in the treatment of cancer.
Studies show that statins can have a dramatic inhibitory effect on growth and development. As the researchers managed to identify the enzyme involved, they can also explain how the effect arises at molecular level. Not least that they can prevent the growth of cancer cells caused by lipid-modified proteins, but also that they can be effective in the treatment of diabetes and neurological disorders such as Parkinson's. In one of my earlier blog, I have mentioned about the simvastin (Simvastatin prevents progression of Parkinson's Disease ?).
So in the days to come statins may be useful as anticancer, anti diabetic and even to treat Parkinsons disaese....
Source : http://www.science.gu.se/english/News/News_detail/Cholesterol-lowering_medicines_may_be_effective_against_cancer.cid898016
Friday, November 29, 2013
Cinnamon May Help Ease Common Cause of Infertility, Study Says...
"There is a lot of interest in homeopathic or natural remedies for this condition," said study author Dr. Daniel Kort, a postdoctoral fellow in reproductive endocrinology at the medical center. "This may be something we can do using a totally natural substance that can help a large group of patients."
"Any work that's something nutritional in nature and seems to affect the abnormal physiology of polycystic ovaries is welcome," Hershlag said. "If they want to spice up their life and take it, that's fine , but I think the best thing to do when you have polycystic ovaries is to be under the control of a physician."
Wednesday, June 10, 2015
Glyxambi for Type 2 diabetes treatment now available by prescription across the U.S.
Monday, August 20, 2012
Investigational ultra-long-acting insulin degludec reduces rates of nocturnal hypoglycaemia in type 2 diabetes patients versus insulin glargine...
"Nocturnal, or night-time, hypoglycaemia is a particular challenge for people living with diabetes, as these episodes are often unpredictable and difficult to detect", said Bernard Zinman, lead author and director of the diabetes centre at Mount Sinai Hospital, and professor of medicine, University of Toronto: "This study demonstrated that treatment with insulin degludec significantly reduced the rate of nocturnal hypoglycaemia".
- Nocturnal hypoglycaemic rates were significantly lower by 36% with insulin degludec than with insulin glargine (0.25 versus 0.39 episodes per patient per year; p=0.04).
- Overall confirmed hypoglycaemic rates were 1.52 versus 1.85 episodes per patient per year for insulin degludec and insulin glargine respectively (p=0.11).
- Overall severe hypoglycaemia was infrequent in both treatment populations, but it was significantly lower with insulin degludec than with insulin glargine (0.003 versus 0.023 episodes/patient-year; p=0.02).
- At one year, this noninferiority, treat-to-target trial demonstrated comparable HbA1c reductions with insulin degludec versus insulin glargine (-1.06% versus -1.19%).**
- Fasting plasma glucose (FPG) reductions were significantly greater with insulin degludec than with insulin glargine (-67.7 versus -59.5 mg/dl, estimated treatment difference (EDT) -7.7 mg/dl, p=0.005).
Tuesday, October 20, 2009
Mangosteen Juice for diabetic obese patients?
Mangosteen is typically advertised and marketed as part of an emerging category of novel functional foods sometimes called "superfruits" presumed to have a combination of 1) appealing subjective characteristics, such as taste, fragrance and visual qualities, 2) nutrient richness, 3) antioxidant strength and 4) potential impact for lowering risk against human diseases.
Though the antioxidant strength was known earlier, a recent study by Dr. Jay Udani and co workers is interesting and as per the claim by the authors, mangosteen juice has anti-inflammatory properties which could prove to be valuable in preventing the development of heart disease and diabetes in obese patients. For people drinking over half a liter of mangosteen juice a day, the degree of reduction in CRP levels was statistically significant – a reduction of 1.33mg/L compared to an increase of 0.9mg/L in the placebo group. Inflammation, as measured here by CRP, is a predictor of cardiovascular disease and a precursor of metabolic syndrome. Reducing inflammation in obese people is a treatment goal, and a natural treatment may be preferable to other treatments which may carry the risk of side effect. Though further studies with a larger population are required to confirm and further define the benefits of this juice, which was safe at all dosages tested its a good achievement. More...
Wednesday, August 14, 2013
Chelsea Therapeutics Announces FDA Acceptance of Northera (droxidopa) NDA Resubmission
Monday, May 26, 2014
Research explains action of drug that may slow aging, related disease
been eaten, energy is available and it's okay for cell proliferation, protein synthesis and growth to proceed.
Aside from a food intake in laboratory mice that's about 40 percent fewer calories than normal, however, it's been found that another way to activate this pathway is with rapamycin, which appears to have a significant impact even when used late in life. Some human clinical trials are already underway exploring this potential.
Nonetheless, the potential of this work is exciting."